Why are US steel tariffs doubling?
How will Ukraine drone strikes impact Russia?
What caused Tesla Superchargers removal in New Jersey?
Why is OpenAI's CEO pivotal now?
How are tariffs affecting Walmart and Target prices?
What’s behind the surge in Nvidia stock?
Why was NASA nominee Jared Isaacman withdrawn?
How Making GLP-1s Available Over the Counter Can Unlock Their Full Potential
reason.com/2025/05/31/unlocking-the-full-potential-of-glp-1s
When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the first glucagon-like peptide-1 (GLP-1) agonist to treat Type 2 diabetes. But this new drug class had the potential to treat a host of other problems.
GLP-1 agonists…
This story appeared on reason.com, 2025-05-31 10:00:43.